<p>Twelve Points Wealth Management LLC 在最近向证券交易委员会（SEC）提交的文件中表示，在第四季度将其在化工公司 Chemours（纽约证券交易所代码：CC - 免费报告）的持股增加了 42.8%。该机构投资者在此期间购买了额外的 23,490 股后，持有 78,325 股该公司的股票。截至其最近向证券交易委员会（SEC）提交的文件，Twelve Points Wealth Management LLC 持有 Chemours 约 0.05% 的股份，价值 1,324,000 美元。</p>
<ul>
<li>人工智能需求为这三家核能领导者带来机会</li>
</ul>
<p>其他对冲基金最近也增加或减少了对该公司的持股。KBC Group NV 在第三季度将其在 Chemours 的持股增加了 19.5%。KBC Group NV 目前持有 4,468 股该公司的股票，价值 91,000 美元，此前在上个季度购买了 728 股。Blue Trust Inc.在第三季度将其在 Chemours 的持股增加了 166.9%。Blue Trust Inc.目前持有 1,169 股该公司的股票，价值 26,000 美元，此前在上个季度购买了 731 股。GAMMA Investing LLC 在第四季度将其在 Chemours 的持股增加了 99.7%。GAMMA Investing LLC 目前持有 1,532 股该公司的股票，价值 26,000 美元，此前在上个季度购买了 765 股。阿拉斯加州财政部在第三季度将其在 Chemours 的持股增加了 7.3%。阿拉斯加州财政部目前持有 17,205 股该公司的股票，价值 349,000 美元，此前在此期间购买了 1,175 股。最后，Signaturefd LLC 在第三季度将其在 Chemours 的持股增加了 163.7%。Signaturefd LLC 目前持有 1,959 股该公司的股票，价值 40,000 美元，此前在上个季度购买了 1,216 股。76.26% 的股票由机构投资者和对冲基金持有。</p>
<h2>内部人员买卖</h2>
<p>在其他消息中，SVP Alvenia Scarborough 于 11 月 7 日星期四出售了 7,500 股该公司的股票。股票以平均价格 20.64 美元出售，总交易额为 154,800.00 美元。出售完成后，这位高级副总裁现在持有 16,645 股该公司的股票，价值 343,552.80 美元。这代表了他们持股的 31.06% 的减少。该交易在向证券交易委员会的文件中披露，相关信息可通过此链接获取。当前 0.47% 的股票由内部人员持有。</p>
<h2>分析师评级变动</h2>
<ul>
<li>嘉年华：2025 年投资这只股票的四个理由</li>
</ul>
<p>CC 已成为多份研究报告的主题。BMO 资本市场在 10 月 7 日的报告中将 Chemours 的目标股价从 30.00 美元提高至 32.00 美元，并给予该股票 “跑赢大盘” 的评级。巴克莱在 11 月 5 日的研究报告中将 Chemours 的目标股价从 21.00 美元提高至 23.00 美元，并给予该股票 “持平” 的评级。高盛在 1 月 7 日的研究报告中将 Chemours 的目标股价从 24.00 美元下调至 21.00 美元，并对该公司设定了 “中性” 的评级。瑞穗在 1 月 7 日的研究报告中将 Chemours 的目标股价从 22.00 美元下调至 21.00 美元，并对该股票设定了 “中性” 的评级。最后，Truist Financial 在周二开始对 Chemours 进行覆盖。他们对该公司设定了 “买入” 评级和 27.00 美元的目标股价。五位股票研究分析师对该股票给予了持有评级，四位分析师给予了买入评级。根据 MarketBeat 的数据，Chemours 目前的平均评级为 “持有”，平均目标股价为 24.11 美元。</p>
<p><strong>获取我们对 CC 的最新分析</strong></p>
<h2>Chemours 股价下跌 1.8%</h2>
<ul>
<li>打破常规：三只非科技股准备在 2025 年大幅上涨</li>
</ul>
<p>CC 股票在周三开盘价为 18.76 美元。Chemours 公司的 1 年最低价为 15.10 美元，1 年最高价为 31.76 美元。该公司的市值为 28 亿美元，市盈率为 37.51，贝塔值为 1.83。该公司的债务与股本比率为 6.05，流动比率为 1.73，速动比率为 0.92。该股票的 50 日简单移动平均线为 19.18 美元，200 日简单移动平均线为 19.55 美元。</p>
<p>Chemours（纽约证券交易所代码：CC - 获取免费报告）最近于 11 月 4 日星期一发布了季度财报。这家特种化学公司报告本季度每股收益（EPS）为 0.40 美元，超出市场共识预期的 0.32 美元，超出幅度为 0.08 美元。该公司本季度的收入为 15 亿美元，而市场共识预期为 14.4 亿美元。Chemours 的净利润率为 1.34%，股本回报率为 29.48%。与去年同期相比，该公司的收入增长了 0.9%。去年同期，该公司每股收益为 0.64 美元。股票研究分析师预计 Chemours 公司在当前财年将发布 1.19 美元的每股收益。</p>
<h2>Chemours 公司简介</h2>
<p>（免费报告）</p>
<p>Chemours 公司在北美、亚太地区、欧洲、中东、非洲和拉丁美洲提供性能化学品。它通过三个部门运营：钛技术、热能与专业解决方案，以及先进性能材料。钛技术部门提供 TiO2 颜料，品牌为 Ti-Pure，用于在各种应用中提供白度、亮度、不透明度、耐用性、效率和保护，例如建筑和工业涂料、柔性和刚性塑料包装、聚氯乙烯、用于家具和建筑材料的层压纸、涂层纸和用于包装的涂层纸板。</p>
<h2>特色文章</h2>
<ul>
<li>我们更看好的五只股票，而不是 Chemours</li>
<li>ETF 会支付股息吗？你需要知道的事项</li>
<li>苹果股价反弹：在财报发布前值得购买吗？</li>
<li>3 只股票引领 meme 股票复兴</li>
<li>美国航空：行业逆风还是内部缺陷？</li>
<li>什么是股息竞争者？投资股息竞争者</li>
<li>3 只运输股票引领市场动能</li>
</ul>
<p><strong>想看看其他对 CC 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取最新的 13F 文件和 The Chemours Company (NYSE:CC - 免费报告) 的内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUND?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUND"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Chemours 吗？</h2>
<p>在考虑 Chemours 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛的市场注意到之前立即购买的股票……而 Chemours 并不在名单上。</p>
<p>虽然 Chemours 目前在分析师中被评为 “持有”，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Twelve Points Wealth Management LLC 在第四季度将其在化工公司（NYSE:CC）的股份增加了 42.8%，持有 78,325 股，价值 132 万美元。其他机构投资者也调整了他们的持股。内部人士 Alvenia Scarborough 出售了 7,500 股，减少了 31.06% 的持股比例。分析师的评级不一，目标价范围从 21 美元到 32 美元不等。Chemours 的股票开盘价为 18.76 美元，市值为 28 亿美元，市盈率为 37.51</p>

<p>Twelve Points Wealth Management LLC boosted its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 42.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,325 shares of the specialty chemicals company's stock after buying an additional 23,490 shares during the period. Twelve Points Wealth Management LLC owned approximately 0.05% of Chemours worth $1,324,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>Twelve Points Wealth Management LLC 在最近向证券交易委员会（SEC）提交的文件中表示，在第四季度将其在化工公司 Chemours（纽约证券交易所代码：CC - 免费报告）的持股增加了 42.8%。该机构投资者在此期间购买了额外的 23,490 股后，持有 78,325 股该公司的股票。截至其最近向证券交易委员会（SEC）提交的文件，Twelve Points Wealth Management LLC 持有 Chemours 约 0.05% 的股份，价值 1,324,000 美元。</p>
</div><ul>
<li>AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders</li>
</ul>
<div class="lb-trans"><ul>
<li>人工智能需求为这三家核能领导者带来机会</li>
</ul>
</div><p>Other hedge funds also recently added to or reduced their stakes in the company. KBC Group NV grew its holdings in shares of Chemours by 19.5% during the third quarter. KBC Group NV now owns 4,468 shares of the specialty chemicals company's stock valued at $91,000 after buying an additional 728 shares during the last quarter. Blue Trust Inc. grew its stake in Chemours by 166.9% during the 3rd quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company's stock valued at $26,000 after purchasing an additional 731 shares during the last quarter. GAMMA Investing LLC grew its stake in Chemours by 99.7% during the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock valued at $26,000 after purchasing an additional 765 shares during the last quarter. State of Alaska Department of Revenue increased its holdings in shares of Chemours by 7.3% in the third quarter. State of Alaska Department of Revenue now owns 17,205 shares of the specialty chemicals company's stock valued at $349,000 after purchasing an additional 1,175 shares during the period. Finally, Signaturefd LLC raised its stake in shares of Chemours by 163.7% in the third quarter. Signaturefd LLC now owns 1,959 shares of the specialty chemicals company's stock worth $40,000 after purchasing an additional 1,216 shares during the last quarter. 76.26% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他对冲基金最近也增加或减少了对该公司的持股。KBC Group NV 在第三季度将其在 Chemours 的持股增加了 19.5%。KBC Group NV 目前持有 4,468 股该公司的股票，价值 91,000 美元，此前在上个季度购买了 728 股。Blue Trust Inc.在第三季度将其在 Chemours 的持股增加了 166.9%。Blue Trust Inc.目前持有 1,169 股该公司的股票，价值 26,000 美元，此前在上个季度购买了 731 股。GAMMA Investing LLC 在第四季度将其在 Chemours 的持股增加了 99.7%。GAMMA Investing LLC 目前持有 1,532 股该公司的股票，价值 26,000 美元，此前在上个季度购买了 765 股。阿拉斯加州财政部在第三季度将其在 Chemours 的持股增加了 7.3%。阿拉斯加州财政部目前持有 17,205 股该公司的股票，价值 349,000 美元，此前在此期间购买了 1,175 股。最后，Signaturefd LLC 在第三季度将其在 Chemours 的持股增加了 163.7%。Signaturefd LLC 目前持有 1,959 股该公司的股票，价值 40,000 美元，此前在上个季度购买了 1,216 股。76.26% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部人员买卖</h2>
</div><p>In other news, SVP Alvenia Scarborough sold 7,500 shares of the company's stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $20.64, for a total transaction of $154,800.00. Following the completion of the sale, the senior vice president now owns 16,645 shares of the company's stock, valued at $343,552.80. This represents a 31.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. 0.47% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在其他消息中，SVP Alvenia Scarborough 于 11 月 7 日星期四出售了 7,500 股该公司的股票。股票以平均价格 20.64 美元出售，总交易额为 154,800.00 美元。出售完成后，这位高级副总裁现在持有 16,645 股该公司的股票，价值 343,552.80 美元。这代表了他们持股的 31.06% 的减少。该交易在向证券交易委员会的文件中披露，相关信息可通过此链接获取。当前 0.47% 的股票由内部人员持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>Carnival: 4 Reasons to Set Sail in This Stock in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>嘉年华：2025 年投资这只股票的四个理由</li>
</ul>
</div><p>CC has been the topic of several research reports. BMO Capital Markets increased their price target on shares of Chemours from $30.00 to $32.00 and gave the stock an &#34;outperform&#34; rating in a report on Monday, October 7th. Barclays increased their price objective on shares of Chemours from $21.00 to $23.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Tuesday, November 5th. The Goldman Sachs Group decreased their target price on shares of Chemours from $24.00 to $21.00 and set a &#34;neutral&#34; rating for the company in a research report on Tuesday, January 7th. Mizuho cut their price target on Chemours from $22.00 to $21.00 and set a &#34;neutral&#34; rating on the stock in a research report on Tuesday, January 7th. Finally, Truist Financial began coverage on Chemours in a research note on Tuesday. They set a &#34;buy&#34; rating and a $27.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, Chemours presently has an average rating of &#34;Hold&#34; and an average target price of $24.11.</p>
<div class="lb-trans"><p>CC 已成为多份研究报告的主题。BMO 资本市场在 10 月 7 日的报告中将 Chemours 的目标股价从 30.00 美元提高至 32.00 美元，并给予该股票 “跑赢大盘” 的评级。巴克莱在 11 月 5 日的研究报告中将 Chemours 的目标股价从 21.00 美元提高至 23.00 美元，并给予该股票 “持平” 的评级。高盛在 1 月 7 日的研究报告中将 Chemours 的目标股价从 24.00 美元下调至 21.00 美元，并对该公司设定了 “中性” 的评级。瑞穗在 1 月 7 日的研究报告中将 Chemours 的目标股价从 22.00 美元下调至 21.00 美元，并对该股票设定了 “中性” 的评级。最后，Truist Financial 在周二开始对 Chemours 进行覆盖。他们对该公司设定了 “买入” 评级和 27.00 美元的目标股价。五位股票研究分析师对该股票给予了持有评级，四位分析师给予了买入评级。根据 MarketBeat 的数据，Chemours 目前的平均评级为 “持有”，平均目标股价为 24.11 美元。</p>
</div><p><strong>Get Our Latest Analysis on CC</strong></p>
<div class="lb-trans"><p><strong>获取我们对 CC 的最新分析</strong></p>
</div><h2>Chemours Trading Down 1.8 %</h2>
<div class="lb-trans"><h2>Chemours 股价下跌 1.8%</h2>
</div><ul>
<li>Breaking the Mold: 3 Non-Tech Stocks Ready to Surge in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>打破常规：三只非科技股准备在 2025 年大幅上涨</li>
</ul>
</div><p>Shares of CC stock opened at $18.76 on Wednesday. The Chemours Company has a 1-year low of $15.10 and a 1-year high of $31.76. The company has a market cap of $2.80 billion, a price-to-earnings ratio of 37.51 and a beta of 1.83. The company has a debt-to-equity ratio of 6.05, a current ratio of 1.73 and a quick ratio of 0.92. The stock has a 50 day simple moving average of $19.18 and a 200-day simple moving average of $19.55.</p>
<div class="lb-trans"><p>CC 股票在周三开盘价为 18.76 美元。Chemours 公司的 1 年最低价为 15.10 美元，1 年最高价为 31.76 美元。该公司的市值为 28 亿美元，市盈率为 37.51，贝塔值为 1.83。该公司的债务与股本比率为 6.05，流动比率为 1.73，速动比率为 0.92。该股票的 50 日简单移动平均线为 19.18 美元，200 日简单移动平均线为 19.55 美元。</p>
</div><p>Chemours (NYSE:CC - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.08. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.44 billion. Chemours had a net margin of 1.34% and a return on equity of 29.48%. The company's revenue was up .9% compared to the same quarter last year. During the same period last year, the firm posted $0.64 earnings per share. On average, equities research analysts expect that The Chemours Company will post 1.19 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Chemours（纽约证券交易所代码：CC - 获取免费报告）最近于 11 月 4 日星期一发布了季度财报。这家特种化学公司报告本季度每股收益（EPS）为 0.40 美元，超出市场共识预期的 0.32 美元，超出幅度为 0.08 美元。该公司本季度的收入为 15 亿美元，而市场共识预期为 14.4 亿美元。Chemours 的净利润率为 1.34%，股本回报率为 29.48%。与去年同期相比，该公司的收入增长了 0.9%。去年同期，该公司每股收益为 0.64 美元。股票研究分析师预计 Chemours 公司在当前财年将发布 1.19 美元的每股收益。</p>
</div><h2>Chemours Company Profile</h2>
<div class="lb-trans"><h2>Chemours 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal &amp; Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.</p>
<div class="lb-trans"><p>Chemours 公司在北美、亚太地区、欧洲、中东、非洲和拉丁美洲提供性能化学品。它通过三个部门运营：钛技术、热能与专业解决方案，以及先进性能材料。钛技术部门提供 TiO2 颜料，品牌为 Ti-Pure，用于在各种应用中提供白度、亮度、不透明度、耐用性、效率和保护，例如建筑和工业涂料、柔性和刚性塑料包装、聚氯乙烯、用于家具和建筑材料的层压纸、涂层纸和用于包装的涂层纸板。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Chemours</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Apple Swings to Outperformer: Is It a Buy Ahead of Earnings?</li>
<li>3 Tickers Leading a Meme Stock Revival</li>
<li>American Airlines: Industry Headwinds or Internal Flaws?</li>
<li>What Are Dividend Contenders? Investing in Dividend Contenders</li>
<li>3 Trucking Stocks Leading the Way in Market Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Chemours</li>
<li>ETF 会支付股息吗？你需要知道的事项</li>
<li>苹果股价反弹：在财报发布前值得购买吗？</li>
<li>3 只股票引领 meme 股票复兴</li>
<li>美国航空：行业逆风还是内部缺陷？</li>
<li>什么是股息竞争者？投资股息竞争者</li>
<li>3 只运输股票引领市场动能</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding CC?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CC - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 CC 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取最新的 13F 文件和 The Chemours Company (NYSE:CC - 免费报告) 的内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUND" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Chemours Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Chemours 吗？</h2>
</div><p>Before you consider Chemours, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Chemours 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemours wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛的市场注意到之前立即购买的股票……而 Chemours 并不在名单上。</p>
</div><p>While Chemours currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Chemours 目前在分析师中被评为 “持有”，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

十二点财富管理有限责任公司购买了 Chemours 公司（NYSE:CC）的股票